evolving treatment options in ndmm: transplant-eligible and transplant-ineligible patients
Published 10 months ago • 82 plays • Length 2:18Download video MP4
Download video MP3
Similar videos
-
1:23
the current landscape of treatment for hr-mds: an update from ash 2023
-
1:25
how the role of transplant in all is evolving with the introduction of novel immunotherapies
-
0:45
current landscape of treatment for scd: an update from ash 2023
-
1:34
the evolving role of transplantation
-
1:28
the role of allogeneic transplantation in patients with aml in the frontline setting
-
3:40
master class in transplantation and hematology: highlights
-
2:19
the addition of venetoclax to hyper-cvad-nelarabine and pegylated asparagine in t-all
-
5:46
the use of allogeneic transplantation in the era of checkpoint blockade therapy in hodgkin lymphoma
-
2:33
novel immunotherapies in aml and insights into the future of the treatment landscape
-
5:18
upfront treatment in transplant candidates
-
1:37
transplantation: a holistic approach
-
1:29
the current landscape of maintenace therapy in aml and areas for future exploration
-
5:25
how the aml treatment landscape is changing with the introduction of novel targeted agents
-
3:08
welcome to the video journal of hematology & hematological oncology 🎥🩸
-
0:42
haploidentical transplant in argentina
-
1:29
the current landscape of immunotherapy for aml: an update from ash 2023
-
6:44
the current landscape for the treatment of r/r aml in the post-transplant setting
-
2:09
heart transplantation in attr amyloidosis